Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

: Example Prior Systemic Therapy Statement — Tamoxifen Adjuvant Hormonal Therapy

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:MedicationStatement ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "PriorSystemicTherapyStatementExample"] ; # 
  fhir:meta [
    ( fhir:profile [
fhir:v "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-prior-systemic-therapy-statement"^^xsd:anyURI ;
fhir:l <https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-prior-systemic-therapy-statement>     ] )
  ] ; # 
  fhir:language [ fhir:v "en"] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement PriorSystemicTherapyStatementExample</b></p><a name=\"PriorSystemicTherapyStatementExample\"> </a><a name=\"hcPriorSystemicTherapyStatementExample\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-nccp-prior-systemic-therapy-statement.html\">NCCP Prior Systemic Therapy Statement</a></p></div><p><b>status</b>: Completed</p><p><b>category</b>: <span title=\"Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs HORMONAL-THERAPY}\">Hormonal Therapy</span></p><p><b>medication</b>: <span title=\"Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs TAMOXIFEN}\">Tamoxifen</span></p><p><b>subject</b>: <a href=\"Patient-example-patient.html\">Mary Wanjiku  Female, DoB: 1975-06-15</a></p><p><b>effective</b>: 2018-03-01 --&gt; 2023-02-28</p><p><b>reasonReference</b>: <a href=\"Condition-example-condition.html\">Condition C50 — Malignant neoplasm of breast</a></p><p><b>note</b>: </p><blockquote><div><p>Completed 5 years of adjuvant tamoxifen. Switched to letrozole following menopause in 2021.</p>\n</div></blockquote></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:status [ fhir:v "completed"] ; # 
  fhir:category [
    ( fhir:coding [
fhir:system [
fhir:v "https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs"^^xsd:anyURI ;
fhir:l <https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs>       ] ;
fhir:code [ fhir:v "HORMONAL-THERAPY" ] ;
fhir:display [ fhir:v "Hormonal Therapy" ]     ] )
  ] ; # 
  fhir:medication [
a fhir:CodeableConcept ;
    ( fhir:coding [
fhir:system [
fhir:v "https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs"^^xsd:anyURI ;
fhir:l <https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs>       ] ;
fhir:code [ fhir:v "TAMOXIFEN" ] ;
fhir:display [ fhir:v "Tamoxifen" ]     ] )
  ] ; # 
  fhir:subject [
fhir:l fhir:Patient/example-patient ;
fhir:reference [ fhir:v "Patient/example-patient" ]
  ] ; # 
  fhir:effective [
a fhir:Period ;
fhir:start [ fhir:v "2018-03-01"^^xsd:date ] ;
fhir:end [ fhir:v "2023-02-28"^^xsd:date ]
  ] ; # 
  fhir:reasonReference ( [
fhir:l fhir:Condition/example-condition ;
fhir:reference [ fhir:v "Condition/example-condition" ]
  ] ) ; # 
  fhir:note ( [
fhir:text [ fhir:v "Completed 5 years of adjuvant tamoxifen. Switched to letrozole following menopause in 2021." ]
  ] ) . #